181 related articles for article (PubMed ID: 35749519)
1. Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.
Cox A; Martini A; Ghozlan H; Moroose R; Zhu X; Lee E; Khaled AS; Barr L; Alemany C; Fanaian N; Griffith E; Sause R; Litherland SA; Khaled AR
PLoS One; 2022; 17(6):e0264651. PubMed ID: 35749519
[TBL] [Abstract][Full Text] [Related]
2. Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma.
Cox A; Nierenberg D; Camargo O; Lee E; Khaled AS; Mazar J; Boohaker RJ; Westmoreland TJ; Khaled AR
Front Oncol; 2022; 12():975088. PubMed ID: 36185250
[TBL] [Abstract][Full Text] [Related]
3. Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis.
Showalter AE; Martini AC; Nierenberg D; Hosang K; Fahmi NA; Gopalan P; Khaled AS; Zhang W; Khaled AR
Sci Rep; 2020 Jan; 10(1):798. PubMed ID: 31964905
[TBL] [Abstract][Full Text] [Related]
4. Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators.
Ghozlan H; Showalter A; Lee E; Zhu X; Khaled AR
Front Oncol; 2021; 11():663877. PubMed ID: 33996588
[TBL] [Abstract][Full Text] [Related]
5. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
Guest ST; Kratche ZR; Bollig-Fischer A; Haddad R; Ethier SP
Exp Cell Res; 2015 Mar; 332(2):223-35. PubMed ID: 25704758
[TBL] [Abstract][Full Text] [Related]
6. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
[TBL] [Abstract][Full Text] [Related]
8. Systematic Characterization of Expression Profiles and Prognostic Values of the Eight Subunits of the Chaperonin TRiC in Breast Cancer.
Xu WX; Song W; Jiang MP; Yang SJ; Zhang J; Wang DD; Tang JH
Front Genet; 2021; 12():637887. PubMed ID: 33815471
[TBL] [Abstract][Full Text] [Related]
9. Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer.
Carr AC; Khaled AS; Bassiouni R; Flores O; Nierenberg D; Bhatti H; Vishnubhotla P; Manuel JP; Santra S; Khaled AR
Oncotarget; 2017 Dec; 8(66):110273-110288. PubMed ID: 29299146
[TBL] [Abstract][Full Text] [Related]
10. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
11. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
14. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
15. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
16. Cryopreservation of Circulating Tumor Cells for Enumeration and Characterization.
Nejlund S; Smith J; Kraan J; Stender H; Van MN; Langkjer ST; Nielsen MT; Sölétormos G; Hillig T
Biopreserv Biobank; 2016 Aug; 14(4):330-7. PubMed ID: 27092845
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
[TBL] [Abstract][Full Text] [Related]
18. Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas.
Adams DL; Adams DK; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Breast Cancer Res; 2016 May; 18(1):44. PubMed ID: 27142282
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Clinical Characterization of CCT2 Expression and Prognosis
Liu Q; Qi Y; Kong X; Wang X; Zhang W; Zhai J; Yang Y; Fang Y; Wang J
Front Oncol; 2021; 11():614497. PubMed ID: 33869000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
